NCT06954935 Periorbital Massage for Nausea and Vomiting After Laparoscopic Surgery
| NCT ID | NCT06954935 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Atlas University |
| Condition | Nausea |
| Study Type | INTERVENTIONAL |
| Enrollment | 2 participants |
| Start Date | 2025-04-23 |
| Primary Completion | 2025-08-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2 participants in total. It began in 2025-04-23 with a primary completion date of 2025-08-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Laparoscopic cholecystectomy is one of the commonly used surgical treatment methods for gallbladder diseases. However, many patients experience significant nausea and vomiting after laparoscopic cholecystectomy. It is observed that approximately 20% to 30% of patients experience postoperative nausea and vomiting as the most common complaint after laparoscopic cholecystectomy. This study aims to investigate the effectiveness of periorbital massage in postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.
Eligibility Criteria
Inclusion Criteria: Those who have laparoscopic cholecystectomy surgery under general anesthesia, * Those between the ages of 18-70, * Those who do not have a psychiatric disease, * Those who understand what they read and volunteer patients, * Those who do not have a hearing or speech problem, Exclusion Criteria: * Patients undergoing emergency surgery, * Patients with psychiatric disorders * Patients who have taken another antiemetic drug within 24 hours before surgery
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06954935 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Nausea. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06954935 currently recruiting?
Yes, NCT06954935 is actively recruiting participants. Contact the research team at cagla.toprak@atlas.edu.tr for enrollment information.
Where is the NCT06954935 trial being conducted?
This trial is being conducted at Gaziantep, Turkey (Türkiye).
Who is sponsoring the NCT06954935 clinical trial?
NCT06954935 is sponsored by Atlas University. The trial plans to enroll 2 participants.